1. Home
  2. AWX vs PHIO Comparison

AWX vs PHIO Comparison

Compare AWX & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AWX

Avalon Holdings Corporation

N/A

Current Price

$2.55

Market Cap

10.3M

Sector

Utilities

ML Signal

N/A

Logo Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

N/A

Current Price

$1.27

Market Cap

12.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AWX
PHIO
Founded
1998
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3M
12.5M
IPO Year
1998
2011

Fundamental Metrics

Financial Performance
Metric
AWX
PHIO
Price
$2.55
$1.27
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$10.67
AVG Volume (30 Days)
2.3K
2.4M
Earning Date
01-01-0001
06-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$53,090,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.14
N/A
52 Week Low
$2.10
$0.81
52 Week High
$5.43
$4.19

Technical Indicators

Market Signals
Indicator
AWX
PHIO
Relative Strength Index (RSI) 43.16 57.78
Support Level $2.47 $1.01
Resistance Level $2.62 $1.43
Average True Range (ATR) 0.05 0.08
MACD 0.00 0.02
Stochastic Oscillator 8.70 95.19

Price Performance

Historical Comparison
AWX
PHIO

About AWX Avalon Holdings Corporation

Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

Share on Social Networks: